Intrinsic Value of S&P & Nasdaq Contact Us

Innovative Eyewear, Inc. LUCY NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
57/100
3/7 Pass
SharesGrow Intrinsic Value
$5,094.48
+467283.5%

Innovative Eyewear, Inc. (LUCY) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.

Analysts estimate Earnings Per Share (EPS) of $-5.19 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-4.47 vs est $-5.19 (beat +13.9%). 2025: actual $-1.90 vs est $-2.19 (beat +13.2%). Analyst accuracy: 84%.

LUCY Analyst Ratings

Buy
1
Ratings
1 Buy
Based on 1 analysts giving stock ratings to Innovative Eyewear, Inc. in the past 3 months
Rating breakdown
Buy
1 100%
100%
Buy
1 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — LUCY

84%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$4.47 vs Est –$5.19 ▲ 16.1% off
2025 Actual –$1.90 vs Est –$2.19 ▲ 15.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — LUCY

94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.002B vs Est $0.002B ▲ 2.2% off
2025 Actual $0.003B vs Est $0.003B ▼ 9.0% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message